Bota Biosciences (HK)
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $115M
Investors
- 7
About Bota Biosciences (HK)
Based in Hangzhou, China, and founded in 2019, Bota Biosciences (HK) Limited operates as an industrial biotechnology company that focuses on synthetic biology via utilizing machine learning technology. The company's main business is in Boston, California, and Hangzhou. Bota Biosciences develops a technology platform known as the Bota Freeway, which combines advanced digital tools with lab automation. The company focuses on the development of high-efficiency, green, low-cost, and suitable for large-scale production of industrial biological manufacturing technology through the use of standardized and automated high-throughput wet experimental platforms (Bio-foundry). The company plans to expand its global operations and build out its lab-to-pilot scale platform.
Who invested in Bota Biosciences (HK)
7 investors across 3 rounds
See all investors in Bota Biosciences (HK)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bota Biosciences (HK)
Who invested in Bota Biosciences (HK)?
Bota Biosciences (HK) has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bota Biosciences (HK) raised?
Bota Biosciences (HK) has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bota Biosciences (HK) last raise money?
Bota Biosciences (HK)'s most recent round on record is a Series B, in Jul 2021.
What does Bota Biosciences (HK) do?
Based in Hangzhou, China, and founded in 2019, Bota Biosciences (HK) Limited operates as an industrial biotechnology company that focuses on synthetic biology via utilizing machine learning technology.
Where is Bota Biosciences (HK) headquartered?
Bota Biosciences (HK) is headquartered in Hangzhou, China.
Which VCs invest in companies like Bota Biosciences (HK)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Bota Biosciences (HK)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Bota Biosciences (HK)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.